Back to
CITADEL ADVISORS LLC
CPHI5 quarters
Position history for
CITADEL ADVISORS LLC's holdings in CHINA PHARMA HLDGS INC
Yes. Citadel Advisors holds 125,445 shares of CPHI (China Pharma), worth $82,806, as of its Q2 2026 13F filing. It increased the position from 12,924 shares in Q1 2026. Citadel Advisors has held CPHI since Q1 2026, across 2 quarterly 13F filings.
Current Value
$82,806
Current Shares
125,445
Total Value Change
+$41,511
Total Shares Change
+102,375
Quarter-by-Quarter History
Other major holders of CPHI: UBS Group AG, HRT FINANCIAL LP, RENAISSANCE TECHNOLOGIES LLC